Skip to main content
Contact Us
Subscribe
E-Edition
63°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about XLRN
Recent news which mentions XLRN
3 Dow Stocks to Take Seriously in 2023
November 29, 2022
Tickers
AAPL
BRK-A
BRK-B
HD
Tags
XLRN
OXY
OGN
From
InvestorPlace
Is Merck Stock a Buy?
November 20, 2021
Tickers
GILD
MRK
REGN
XLRN
Tags
Market News
GILD
MRK
From
Motley Fool
Merck Is a Dividend Play Ready to Get Back in Gear
November 16, 2021
Tickers
ABBV
BNTX
MRK
PFE
Tags
NYSE:MRK,NASDAQ:XLRN,NYSE:PFE,NASDAQ:BNTX,NYSE:ABBV
PFE
XLRN
From
InvestorPlace
Is Merck's Planned Acquisition of Acceleron in Trouble?
November 12, 2021
Tickers
MRK
XLRN
Tags
Recent Press Releases
Market News
XLRN
From
Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Tickers
ACHV
ACIU
AEMD
AGEN
Tags
MNKD
CAPR
Biotech
From
Benzinga
3 Dow Stocks That Are Screaming Buys in November
November 09, 2021
Tickers
DJI
IBM
MRK
PFE
Tags
IBM
PFE
XLRN
From
Motley Fool
3 Best Biotech Stocks to Buy in November
November 08, 2021
Tickers
ABBV
AZN
BMY
MRK
Tags
Recent Press Releases
ABBV
XLRN
From
Motley Fool
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
November 06, 2021
Tickers
AUPH
BMY
MRK
XLRN
Tags
XLRN
Recent Press Releases
MRK
From
Motley Fool
Merck Pushes Acceleron Buyout By Refiling For Antitrust Review
November 01, 2021
Tickers
MRK
XLRN
Tags
Market News
M&A
MRK
From
Benzinga
2 Top Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash
October 27, 2021
Tickers
MRK
PFE
TRIL
XLRN
Tags
Market News
^GSPC
MRK
From
Motley Fool
2 Biotech Stocks That Could Go Parabolic This Week
October 24, 2021
Tickers
AUPH
BMY
DWAC
OCGN
Tags
BMY
OCGN
AUPH
From
Motley Fool
Bristol Myers Pledges To Offload Acceleron Shares: Bloomberg
October 21, 2021
Tickers
BMY
MRK
XLRN
Tags
General
BMY
MRK
From
Benzinga
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
Tickers
ABBV
AMGN
AZN
BMY
Tags
MRK
BMY
AZN
From
Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
Tickers
ALLO
ALPMF
BIIB
BLUE
Tags
PFE
XBI
XLRN
From
Motley Fool
Better COVID-19 Stock: Merck or Pfizer?
October 16, 2021
Tickers
BNTX
MRK
PFE
TRIL
Tags
PFE
XLRN
TRIL
From
Motley Fool
3 Top Warren Buffett Stocks to Buy in October
October 10, 2021
Tickers
AAPL
BMY
BRK-A
BRK-B
Tags
AAPL
MRK
BMY
From
Motley Fool
3 Reasons to Buy Merck Stock Right Now
October 09, 2021
Tickers
MRK
XLRN
Tags
MRK
XLRN
Market News
From
Motley Fool
Is an Acquisition of Acceleron a Smart Move for Merck?
October 08, 2021
Tickers
BMY
MRK
XLRN
Tags
MRK
XLRN
BMY
From
Motley Fool
Expert Ratings For Acceleron Pharma
October 07, 2021
Tickers
XLRN
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
Tickers
ALLY
ARGX
ATO
BAC
Tags
NSA
EXR
FIBK
From
Benzinga
Where Acceleron Pharma Stands With Analysts
October 04, 2021
Tickers
XLRN
Tags
BZI/AAR
Analyst Ratings
XLRN
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2021
October 04, 2021
Tickers
AKAM
AMPY
AON
CLMT
Tags
XLRN
Benzinga
NRDY
From
Benzinga
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
Tickers
ADVM
ASND
BCYC
CCXI
Tags
CLSD
IBB
FDA
From
Benzinga
Activist Investor Thinks Merck Undervalues Acceleron Buy
October 01, 2021
Tickers
MRK
XLRN
Tags
XLRN
Briefs
Movers
From
Benzinga
Expert Ratings For Acceleron Pharma
October 01, 2021
Tickers
XLRN
Tags
XLRN
Analyst Ratings
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021
October 01, 2021
Tickers
AADI
ALC
ALIZY
ALZN
Tags
CNP
BE
Intraday Update
From
Benzinga
10 Biggest Price Target Changes For Friday
October 01, 2021
Tickers
BABA
BBBY
DASH
GIS
Tags
Pre/Market Outlook
GIS
Industrials
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
September 30, 2021
Tickers
AANNF
ABCB
ABG
ACCD
Tags
BCYC
PEG
LAC
From
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Tickers
ABBV
ADMA
AGTC
AIM
Tags
BNR
PASG
GLPG
From
Benzinga
Merck Seals Acceleron Pharma Deal For $180/Share: Highlights
September 30, 2021
Tickers
BMY
MRK
XLRN
Tags
General
XLRN
Briefs
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.